Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

Negative pressure wound therapy: Data presented by Smith & Nephew Oct. 23 at the Annual Clinical Symposium on Advances in Skin and Wound Care show that gauze-based negative pressure wound therapy significantly reduced wound dimensions in a prospective, multi-center clinical evaluation of 131 non-grafted patients. The weekly reduction rates in wound area, depth and volume were 8.3%, 15.8% and 20.5%, respectively, Smith & Nephew said. There also was a significant reduction in wound exudate levels from baseline to treatment discontinuation, and a significant increase in the percentage area of the wound bed composed of red granulation tissue over the course of treatment. In a subset analysis of 23 patients with split-thickness skin grafts (STSG) treated with NPWT, the average graft "take" was 83%, including an average take of 50% for diabetics and 95% for non-diabetics. Smith & Nephew markets the Renasys line of NPWT devices

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts